During India’s nationwide 100-day TB campaign, AI-enabled handheld X-ray devices combined with Molbio’s Truenat molecular testing platform played a key role in screening over 12 crore people, identifying 2.85 lakh asymptomatic TB cases. In an interview with Modern Ghana, health officials explained how this technology combination enabled rapid diagnosis and treatment access in high-risk and remote communities. Truenat’s portability and real-time testing capability allowed immediate confirmation of presumptive TB cases identified by AI-powered X-rays—significantly accelerating India’s TB elimination efforts and closing diagnostic gaps among the underserved.